Activation of NF-κB by TGF-β1 has been described in models of bleomycin-induced pulmonary fibrosis [49] and in osteoclasts, where it activates TAK1/MEK/AKT/NF-κB to promote their differentiation and survival [50]. Here, MAP2K7 is linked to pulmonary fibrosis.